dc.creator | Neromyliotis E., Kalamatianos T., Paschalis A., Komaitis S., Fountas K.N., Kapsalaki E.Z., Stranjalis G., Tsougos I. | en |
dc.date.accessioned | 2023-01-31T09:40:06Z | |
dc.date.available | 2023-01-31T09:40:06Z | |
dc.date.issued | 2022 | |
dc.identifier | 10.1002/jmri.27378 | |
dc.identifier.issn | 10531807 | |
dc.identifier.uri | http://hdl.handle.net/11615/77145 | |
dc.description.abstract | Meningioma is one of the most frequent primary central nervous system tumors. While magnetic resonance imaging (MRI), is the standard radiologic technique for provisional diagnosis and surveillance of meningioma, it nevertheless lacks the prima facie capacity in determining meningioma biological aggressiveness, growth, and recurrence potential. An increasing body of evidence highlights the potential of machine learning and radiomics in improving the consistency and productivity and in providing novel diagnostic, treatment, and prognostic modalities in neuroncology imaging. The aim of the present article is to review the evolution and progress of approaches utilizing machine learning in meningioma MRI-based sementation, diagnosis, grading, and prognosis. We provide a historical perspective on original research on meningioma spanning over two decades and highlight recent studies indicating the feasibility of pertinent approaches, including deep learning in addressing several clinically challenging aspects. We indicate the limitations of previous research designs and resources and propose future directions by highlighting areas of research that remain largely unexplored. Level of Evidence: 5. Technical Efficacy Stage: 2. © 2020 International Society for Magnetic Resonance in Medicine. | en |
dc.language.iso | en | en |
dc.source | Journal of Magnetic Resonance Imaging | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091780398&doi=10.1002%2fjmri.27378&partnerID=40&md5=99595568f359590d16c3a725f85bf955 | |
dc.subject | cancer grading | en |
dc.subject | cancer prognosis | en |
dc.subject | contrast enhancement | en |
dc.subject | convolutional neural network | en |
dc.subject | feasibility study | en |
dc.subject | human | en |
dc.subject | image segmentation | en |
dc.subject | machine learning | en |
dc.subject | meningioma | en |
dc.subject | nuclear magnetic resonance imaging | en |
dc.subject | perfusion weighted imaging | en |
dc.subject | radiomics | en |
dc.subject | random forest | en |
dc.subject | Review | en |
dc.subject | support vector machine | en |
dc.subject | diagnostic imaging | en |
dc.subject | machine learning | en |
dc.subject | meningioma | en |
dc.subject | nuclear magnetic resonance imaging | en |
dc.subject | prognosis | en |
dc.subject | Humans | en |
dc.subject | Machine Learning | en |
dc.subject | Magnetic Resonance Imaging | en |
dc.subject | Meningeal Neoplasms | en |
dc.subject | Meningioma | en |
dc.subject | Prognosis | en |
dc.subject | John Wiley and Sons Inc | en |
dc.title | Machine Learning in Meningioma MRI: Past to Present. A Narrative Review | en |
dc.type | other | en |